D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$384M |
| 2 |
Apple
AAPL
|
+$377M |
| 3 |
PayPal
PYPL
|
+$368M |
| 4 |
Pfizer
PFE
|
+$339M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.02B |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$732M |
| 3 |
Netflix
NFLX
|
+$461M |
| 4 |
Citigroup
C
|
+$361M |
| 5 |
Booking.com
BKNG
|
+$288M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.52% |
| 2 | Consumer Discretionary | 9.06% |
| 3 | Financials | 8.14% |
| 4 | Healthcare | 8% |
| 5 | Energy | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
PetMed Express
PETS
$42.3M
| $2.63M | ﹤0.01% |
101,752
+8,501
| +9% | +$220K |
|
2877
Stantec
STN
$7.92B
| $2.62M | ﹤0.01% |
52,300
+37,100
| +244% | +$1.92M |
|
2878
CEL-SCI Corp
CVM
$21.3M
| $2.62M | ﹤0.01% |
22,216
+1,368
| +7% | +$223K |
|
2879
PUT
Herbalife
HLF
$1.29B
| $2.62M | ﹤0.01% |
86,200
+56,500
| +190% | +$2.21M |
|
2880
Applied Optoelectronics
AAOI
$7.23B
| $2.62M | ﹤0.01% |
716,365
-68,311
| -9% | -$264K |
|
|
SHAC
2881
DELISTED
SCP & CO Healthcare Acquisition Company Class A Common Stock
SHAC
| $2.61M | ﹤0.01% |
266,500
-167,072
| -39% | -$1.63M |
|
|
DSEY
2882
DELISTED
Diversey Holdings, Ltd. Ordinary Shares
DSEY
| $2.6M | ﹤0.01% |
344,146
+263,695
| +328% | +$2.66M |
|
|
RXDX
2883
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $2.6M | ﹤0.01% |
68,903
+52,432
| +318% | +$2.07M |
|
|
GNAC
2884
DELISTED
Group Nine Acquisition Corp. Class A Common stock
GNAC
| $2.6M | ﹤0.01% |
265,508
-50,904
| -16% | -$497K |
|
2885
CALL
Aflac
AFL
$64.8B
| $2.6M | ﹤0.01% |
+40,300
| New | +$2.52M |
|
2886
PAR Technology
PAR
$695M
| $2.59M | ﹤0.01% |
64,295
-16,922
| -21% | -$694K |
|
2887
CALL
Realty Income
O
$60.1B
| $2.59M | ﹤0.01% |
37,400
+14,300
| +62% | +$972K |
|
|
GGPI
2888
DELISTED
Gores Guggenheim, Inc. Class A Common Stock
GGPI
| $2.59M | ﹤0.01% |
227,981
-198,504
| -47% | -$2.2M |
|
|
SHYF
2889
DELISTED
The Shyft Group
SHYF
| $2.59M | ﹤0.01% |
71,765
+64,793
| +929% | +$2.75M |
|
|
REGI
2890
DELISTED
Renewable Energy Group, Inc.
REGI
| $2.59M | ﹤0.01% |
42,635
-9,781
| -19% | -$474K |
|
2891
Opendoor
OPEN
$3.69B
| $2.58M | ﹤0.01% |
+308,368
| New | +$2.87M |
|
|
SCHW
2892
CALL
Charles Schwab
SCHW
$181B
| $2.58M | ﹤0.01% |
30,600
-264,400
| -90% | -$23.3M |
|
|
GTPB
2893
DELISTED
Gores Technology Partners II, Inc. Class A Common
GTPB
| $2.58M | ﹤0.01% |
263,796
-32,967
| -11% | -$322K |
|
2894
CALL
QuidelOrtho
QDEL
$1.13B
| $2.58M | ﹤0.01% |
22,900
| – | – |
|
2895
CALL
Synaptics
SYNA
$4.25B
| $2.57M | ﹤0.01% |
12,900
+700
| +6% | +$155K |
|
2896
TG Therapeutics
TGTX
$8.19B
| $2.57M | ﹤0.01% |
270,351
+253,317
| +1,487% | +$2.93M |
|
2897
PUT
Capri Holdings
CPRI
$1.82B
| $2.57M | ﹤0.01% |
50,000
-94,300
| -65% | -$5.65M |
|
2898
JD.com
JD
$43.6B
| $2.57M | ﹤0.01% |
44,408
-431,877
| -91% | -$29.3M |
|
2899
PUT
Inspire Medical Systems
INSP
$1.44B
| $2.57M | ﹤0.01% |
10,000
| – | – |
|
|
TWOA
2900
DELISTED
two
TWOA
| $2.57M | ﹤0.01% |
262,378
+38,706
| +17% | +$376K |
|
Similar funds
D.E. Shaw & Co's Q1 2022 Portfolio in Review
As of Q1 2022, D.E. Shaw & Co held 6,280 positions worth $107B, down 11% from $121B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
D.E. Shaw & Co withdrew a net $14.2B in Q1 2022, closing 805 positions and reducing 2,078 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $1.02B position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, D.E. Shaw & Co opened a new position in Cenovus Energy worth $141M.
- D.E. Shaw & Co's largest Q1 2022 buy was Cenovus Energy: 8,428,527 shares worth $141M.
- D.E. Shaw & Co added most to Starbucks in Q1 2022, an estimated $384M increase.
- D.E. Shaw & Co's biggest Q1 2022 reduction was Netflix, cutting an estimated $461M.
- D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q1 2022, selling an estimated $1.02B.
- D.E. Shaw & Co's ten largest holdings make up 9.3% of its $107B portfolio in Q1 2022.
- D.E. Shaw & Co opened 934 new positions and closed 805 in Q1 2022.
- D.E. Shaw & Co's portfolio value fell 11% quarter-over-quarter to $107B.
Based on D.E. Shaw & Co's 13F filing for Q1 2022, filed 16 May 2022.